David Chitayat, MD

  • 2Articles
  • 26.4KReads1
  • 2021Active
  • 10Collaborators
  • 23Citations2

About

David Chitayat, MD, has published research focused on the reproductive safety of second-generation antipsychotics, particularly in women with bipolar disorder. His work includes updated data from the Massachusetts General Hospital National Pregnancy Registry for atypical antipsychotics. Chitayat has collaborated frequently with co-authors such as Adele C. Viguera and Lee S. Cohen.

Publications

JCP
Correction

Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

October 5, 2021

, , , et al
JCP
Reproductive Safety of Second-Generation Antipsychotics
Original Research

Reproductive Safety of Second-Generation Antipsychotics

August 3, 2021

What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe